Thank you, Dan. As this call comes on the heels of our announcing the FDA's acceptance of the NDA for lorundestat, the treatment of adult patients with hypertension in combination with other ...

Robert P. Eno: Thank you, operator. The topics we will cover on today's call are listed on the slide. We will start with an overview of the HeartBeam, Inc. system, the core technology in our platform.

The insurer would also need to raise it base pricing to account for the likelihood of higher average claim costs under the AI arrangement (because brokers effectively act as a filter, helping insurers ...

Share Market Highlights - Find here all the highlights related to Sensex, Nifty, BSE, NSE, share prices and Indian stock ...